CAMRAS VISION, INC.
Biocompatible microchannel shunt device that regulates intraocular pressure by draining aqueous humor externally, with titratable design enabling noninvasive postoperative IOP adjustment
- Sector
- Medtech
- Headquarters
- RESEARCH TRIANGLE PARK, NC
- Founded
- 2010
- Latest Form D
- $3M, Nov 2017
- Total capital
- $5.8M
- Federal grants
- $2.6M
- 5 awards · 2015–2018
- Rank in peer group#432 of 538
- Private capital raised
- $3.2M
- 2 Form D · last Nov 2017
- 107 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 6 pending · first 2019
- Rank in peer group#125 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Safety and Efficacy of a Titratable External Shunt$535K
- Private capital raisedForm D · SEC · 2nd filing$3M
- Federal grantHealth and Human S · Phase II · Safety and Efficacy of a Titratable External Shunt$886K
- Federal grantHealth and Human S · Phase II · Safety and Efficacy of a Titratable External Shunt$300K
- Federal grantNSF · Phase II · SBIR Phase II: Adjustable Eye Pressure Control within an External Shunt$713K
- Private capital raisedForm D · SEC · 1st filing$175K
- Federal grantNSF · Phase I · SBIR Phase I:Feasibility of Adjustable Eye Pressure Control within an External Shunt$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
4months
from CAMRAS VISION, INC.’s first federal award to its first private round.
- First federal award · Jan 2015
- NSF · $150K
- First Form D · May 2015
- $175K · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#125 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Lucinda CamrasResearcherExecutive Officer, Director, PromoterLinked by 2 patents · $2.6M in grants as PI
- Ray KraussExecutive Officer, DirectorNamed in SEC Form D filings
- Roberto AlfaroExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Robert RothmanDirectorNamed in SEC Form D filings
- Timothy WillisDirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 10- GrantedMethod And Apparatus For Reducing Intraocular PressureUSPTOUS 10,524,958
- PendingSystems And Methods For Reducing Intraocular PressureUSPTOApplication 16281601
- GrantedDevice And Method For Reducing Intraocular PressureUSPTOUS 10,369,050
Show all 10 patent records
- Method And Apparatus For Reducing Intraocular PressureJan 7, 2020 · US 10,524,958Granted
- Systems And Methods For Reducing Intraocular PressureAug 22, 2019 · Application 16281601Pending
- Device And Method For Reducing Intraocular PressureAug 6, 2019 · US 10,369,050Granted
- Apparatus And Method For Reducing Intraocular PressureJul 9, 2019 · US 10,342,702Granted
- Device And Method For Reducing Intraocular PressureFeb 12, 2019 · US 10,201,451Granted
- System And A Method For Reducing Pressure In A Pressurized ChamberNov 1, 2018 · Application 15499172Pending
- Apparatus And Method For Reducing Intraocular PressureApplication PCTUS2016046579Pending
- Device And Method For Reducing Intraocular PressureApplication PCTUS2015047080Pending
- A System And A Method For Reducing Pressure In A Pressurized ChamberApplication PCTUS2018029717Pending
- Systems And Methods For Reducing Intraocular PressureApplication PCTUS2019018930Pending
Related companies, and why
- BUY TIME MEDICAL INCSimilar federal contract value in Medtech · null in contracts
- Articulate Biosciences, LLCSimilar federal contract value in Medtech · null in contracts
- Ascent Bio-Nano Technologies, Inc.Similar federal contract value in Medtech · null in contracts
- 37DEGREES, INC.Similar federal contract value in Medtech · null in contracts
- Acoustic Biosystems, Inc.Similar federal contract value in Medtech · null in contracts
- SENTIOMED, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .